NASDAQ · GDTC
CytoMed Therapeutics Ltd
Smart money pulse
What insiders and funds are doing
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
−100 means everyone selling, +100 everyone buying. This is data, not advice.
How the Pulse works
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.
Who owns it
3 funds report owning GDTC, same as the quarter before
Insider trades · last 12 months
Real buys and sales
Last 12 months. No real trades in the last 6.
Showing 1 real trade. Bigger dot means a bigger trade.
Real trades, newest first
Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.
Top holders
Biggest funds in GDTC
| Fund | Value | Change |
|---|---|---|
| Axiom Investment Management LLC | $7.24K | New |
| UBS Group AG | $4.98K | −22% |
| Osaic Holdings, Inc. | $21 | Same |
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.